HK1147700A1 - Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man - Google Patents
Pharmaceutical composition for the treatment of type 2 diabetes in mammals including manInfo
- Publication number
- HK1147700A1 HK1147700A1 HK11101957.6A HK11101957A HK1147700A1 HK 1147700 A1 HK1147700 A1 HK 1147700A1 HK 11101957 A HK11101957 A HK 11101957A HK 1147700 A1 HK1147700 A1 HK 1147700A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diabetes
- treatment
- type
- pharmaceutical composition
- mammals including
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101406134A CN101904840B (en) | 2009-06-08 | 2009-06-08 | Medicinal composition for treating type 2 diabetes of mammal including human |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1147700A1 true HK1147700A1 (en) | 2011-08-19 |
Family
ID=43260529
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11101957.6A HK1147700A1 (en) | 2009-06-08 | 2011-02-28 | Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101904840B (en) |
| HK (1) | HK1147700A1 (en) |
| WO (1) | WO2010142183A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104030967B (en) * | 2013-03-05 | 2018-01-02 | 连云港恒运药业有限公司 | A kind of intermediate of DPP IV inhibitor, its preparation method and the method for DPP IV inhibitor is prepared by it |
| WO2021057661A1 (en) * | 2019-09-27 | 2021-04-01 | 深圳信立泰药业股份有限公司 | Pharmaceutical composition for lowering blood sugar |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045039A (en) * | 2001-09-28 | 2007-10-03 | 太阳医药工业有限公司 | Dosage form for treatment of diabetes mellitus |
| CA2633167A1 (en) * | 2005-12-16 | 2007-07-12 | Merck & Co., Inc. | Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| CN101230059B (en) * | 2007-01-23 | 2011-08-17 | 上海恒瑞医药有限公司 | Bicycle aza alkyl derivative, preparation method and use in medicine thereof |
-
2009
- 2009-06-08 CN CN2009101406134A patent/CN101904840B/en not_active Expired - Fee Related
-
2010
- 2010-05-13 WO PCT/CN2010/072715 patent/WO2010142183A1/en active Application Filing
-
2011
- 2011-02-28 HK HK11101957.6A patent/HK1147700A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101904840A (en) | 2010-12-08 |
| CN101904840B (en) | 2012-02-08 |
| WO2010142183A1 (en) | 2010-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200902374B (en) | Compositions useful for the treatment of diabetes | |
| HK1163500A1 (en) | Pharmaceutical composition for the treatment of heart diseases | |
| IL225198A (en) | Aminotetrahydropyran compounds, pharmaceutical compositions comprising the same and the use thereof for the treatment of diabetes | |
| IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
| HK1170490A1 (en) | Pharmaceutical composition for treating or preventing glaucoma | |
| EP2236149A4 (en) | Medicinal composition | |
| HK1141447A1 (en) | Pharmaceutical composition for the treatment of proliferative diseases | |
| PT2358373E (en) | Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases | |
| IL223289A (en) | Triazine derivatives and pharmaceutical compositions comprising them for the treatment of type 2 diabetes | |
| PL2429507T3 (en) | Phosphate-free pharmaceutical composition for the treatment of glaucoma | |
| IL208463A (en) | 2-heterocyclyl-fused pyrrole compounds, pharmaceutical compositions comprising them and their use in the prophylaxis or treatment of diabetes or obesity | |
| ZA201009072B (en) | Pharmaceutical composition for the treatment of premature ejaculation | |
| PT2842555T (en) | Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines in the treatment of diabetes | |
| HK1156844A1 (en) | Pharmaceutical composition 271 271 | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
| PL2298090T3 (en) | Pharmaceutical or nutraceutical composition | |
| IL200753A (en) | Pharmaceutical composition comprising ib-meca for the treatment of psoriasis | |
| HK1147700A1 (en) | Pharmaceutical composition for the treatment of type 2 diabetes in mammals including man | |
| EP2402342A4 (en) | Pharmaceutical composition for treatment of 2 type diabetes | |
| ZA201204341B (en) | Pharmaceutical composition for treating gutaneous burns | |
| HK1145445A1 (en) | Pharmaceutical composition for losing weight or for treating metabolic syndromes | |
| HK1145447A1 (en) | Pharmaceutical composition for losing weight or for treating metabolic syndromes | |
| SI2344166T1 (en) | Pharmaceutical composition for the treatment of gastrointestinal irritation disorders | |
| PL2307380T3 (en) | N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases | |
| EP2331099A4 (en) | Pharmaceutical compositions for the treatment of diabetes mellitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220606 |